PicksThatMove.com Provides Investment Opinion on Erdene Resource Development, ArQule Inc., YM BioSciences Inc., Superlattice Power Inc. and Farallon Mining Ltd.

CALGARY, Alberta--(BUSINESS WIRE)--

The investment opinions offered below and in this press release are provided by Nick Hunter, RIA, of PicksThatMove.com.

PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the business development level to bring value to shareholders. Some of our past picks had soared over 200%. To view some of our profiled stocks, please visit our website at www.picksthatmove.com.

At PicksThatMove, our team scours the technical and financials of hundreds of companies to identify those stocks showing the greatest potential for growth.

Erdene Resource Development ERD, traded heavily today closing up 66.67% or 0.20 cents at 0.50 on no news. ERD hit a high of 0.54 today surpassing its 52 week-high of 0.40 from last November. ERD Resource is in the business of exploration and development of mineral deposits and is principally focused on the discovery of large tonnage, copper, molybdenum, coal and uranium deposits in Mongolia. Last company announcement from February was with respect to the Donkin Coal Project. Erdene holds a 25% interest in the Donkin Coal Alliance with its partner Xstrata Coal Canada, which holds a 75% interest. Xstrata advised that it will now be developing the project based on the sales into the coking coal market. The revised Donkin Coal Project is expected to produce around 2.75 million tonnes of coking coal. This particular project is located in Cape Breton, Nova Scotia.

ArQule Inc. ARQL, closed up 63.43% or 2.22 at 5.72 on news that its ARQ197 when used together with erlotinib showed a 66% improvement in patients with advanced refractory non-small cell lung cancer. ArQule Inc. is a biotechnology company focused on the research and development of next generation, small-molecule cancer therapeutics. ARQ197 is the company’s lead product which is in Phase 2 clinical development. ArQule is also testing its ARQ621 product which is in the Phase 1 stage. ARQL moved past its 52 week-high of 6.38 to hit the day’s high of 7.49 with a low of 5.71.

YM BioSciences Inc. YMI, is a product development company which identifies and advances a diverse portfolio of promising cancer-related products which are at various stages of development. YMI closed at 1.18, up 3.51%, trading between 1.15 to 1.24. YMI announced that it has been granted approval from the ethics board to expand enrollment in its Phase I/II clinical trial of CYT387. CYT387 is an oral inhibitor targeting the treatment of a group of haematological disorders. This product is for treatment of patients with a chronic debilitating condition where the patient’s bone marrow is replaced by scar tissue.

Superlattice Power Inc. SLPO, closed up 32.35% at 0.045 on heavy volume as it announced the development of its fast charge 80% state of charge battery pack in less than 30 minutes. Technologists at Superlattice have resourced a new cathode material which is marked as safe and environmentally friendly manganese based mixed oxide with minimum thermal run away. Two charger models will be introduced with a power rating from 30kW to 40kW. The charge is in its final stages and will be produced in the USA. Shares of SLPO are trading in the range of 0.038 to 0.06 with its 52 week-high sitting at 0.35 from October 2009.

Farallon Mining Ltd. FAN, traded heavily and closed just a penny shy from reaching its 52 week-high of 0.65, closing up 3.39% or 0.02 cents at 0.61. Farallon Mining is a based in Canada with operations on its zinc polymetallic mine in Mexico. The G9 mine moved into commercial production in April of 2009. Farallon Mining released an update stating that the G9 operations have continued to increase throughput rates in the first quarter of 2010 and are now in steady operation of 1,900 tonnes per day. The company reports that metallurgical recovery has continued to improve over the same period with zinc recovery of 84% and copper recovery of 68% for the month of March.

About PicksThatMove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please follow us on Twitter and Facebook for further investment updates. We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

PicksThatMove.com
Joseph Smith, 1-877-292-3917
info@picksthatmove.com
www.picksthatmove.com

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!